A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study
Noah M. Hahn(Johns Hopkins University), Hristos Z. Kaimakliotis(Indiana University Health), Gary L. Rosner(Johns Hopkins University), Timothy A. Masterson(Indiana University School of Medicine), Emerson A. Lim(Columbia University), David Y.T. Chen(Anesthesiology and Surgical Oncology Research Group), Charles G. Drake(Columbia University Irving Medical Center), Elizabeth R. Plimack(Fox Chase Cancer Center), Daniel M. Geynisman(Fox Chase Cancer Center), Woonyoung Choi(Johns Hopkins University), Burles A. Johnson(Johns Hopkins University), Jason A. Efstathiou(Massachusetts General Hospital), Eric M. Horwitz(Fox Chase Cancer Center), Mary Grace Phelan(Johns Hopkins University), Donald L. Lamm(The University of Texas System), Nabil Adra(Indiana University Health), Daniel Y. Song(Johns Hopkins University), Christopher B. Anderson(Columbia University Irving Medical Center), M.A. Hallman(Fox Chase Cancer Center), David J. McConkey(Johns Hopkins University), Marianna Zahurak(Bloomberg (United States)), Gordon Guo(University of Manitoba), Drew M. Pardoll(Bloomberg (United States)), Phuoc T. Tran(University of Chicago Medical Center), Marc A. Bjurlin, Essel Dulaimi Al-Saleem(Fox Chase Cancer Center), Tracy L. Rose(University of North Carolina at Chapel Hill), Richard E. Greenberg, Trinity J. Bivalacqua(University of Pennsylvania), Luigi Marchionni(Cornell University), Kellie N. Smith(Bloomberg (United States)), Bridget McGuire(Sidney Kimmel Comprehensive Cancer Center), Andrés Matoso(Johns Hopkins University), Alexander Kutikov(Fox Chase Cancer Center), Jeff Smith(Hoosier Cancer Research Network (United States)), Tanya O’Neal(Johns Hopkins University), Israel Deutsch(Columbia University Irving Medical Center), Max Kates(Duke Medical Center), Alex S. Baras(Sidney Kimmel Comprehensive Cancer Center), Michael A. O’Donnell(University of Iowa Health Care)
Cited by 58
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k